Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation

• Publication date

  2013-02-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.112.136085PMID 23275385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertrophic cardiomyopathy

  2013cited by this paper
• Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Multicenter North American Registry

  2012cited by this paper
• Hypertrophic cardiomyopathy with longevity to 90 years or older.

  2012cited by this paper
• Long-Term Survival in Patients With Resting Obstructive Hypertrophic Cardiomyopathy: Comparison of Conservative Versus Invasive Treatment

  2012cited by this paper
• 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.

  2011cited by this paper
• Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.

  2011cited by this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cited by this paper
• Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

  2010cited by this paper
• Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance

  2010cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

  2010cited by this paper
• Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy

  2010cited by this paper
• Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

  2010cited by this paper
• Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography.

  2009cited by this paper
• Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.

  2009cited by this paper
• Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

  2009cited by this paper
• Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.

  2008cited by this paper
• Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy

  2008cited by this paper
• Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

  2008cited by this paper
• Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

  2007cited by this paper
• Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy

  2007cited by this paper
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

  2006cited by this paper
• Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

  2005cited by this paper
• The case for surgery in obstructive hypertrophic cardiomyopathy.

  2004cited by this paper
• Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease

  2003cited by this paper
• Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.

  2003cited by this paper
• Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

  2003cited by this paper
• Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

  2003cited by this paper
• Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

  2000cited by this paper
• Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

  2000cited by this paper
• Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

  2000cited by this paper
• Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.

  1999cited by this paper
• Hypertrophic cardiomyopathy.

  1994cited by this paper
• Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life.

  1989cited by this paper

• Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White Paper.

  2026cites this paper
• Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection

  2026cites this paper
• Exploring the association of electrocardiographic markers and arrhythmic risk in hypertrophic cardiomyopathy: A systematic review and meta-analysis.

  2026cites this paper
• Risk Factors for Progression in Hypertrophic Cardiomyopathy.

  2025cites this paper
• Current management of hypertrophic cardiomyopathy

  2025cites this paper
• Miocardiopatías

  2025cites this paper
• PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis

  2025cites this paper
• Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

  2025cites this paper
• Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy

  2025cites this paper
• Age and Sex Differences in the Risk of Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: A Multi-Centre Cohort Study

  2025influential citation
• Prognostic Implication of Left Ventricular Global Longitudinal Strain in Patients With Hypertrophic Cardiomyopathy and Coexisting Hypertension

  2025cites this paper
• Cardiovascular Health and Outcomes in Carriers With Genetic Variants of Hypertrophic Cardiomyopathy.

  2025cites this paper
• Cardiomyopathy in Older Adults

  2025cites this paper
• Cardiac Magnetic Resonance-Derived Left Ventricular Mechanical Dispersion Improves Risk Stratification of Hypertrophic Cardiomyopathy and its Correlations with Scar Heterogeneity

  2025cites this paper
• Predictors of Arrhythmic Events in Hypertrophic Cardiomyopathy Patients with an Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Network Analysis and Structural Equation Modelling of Genetic and Environmental Factors in Hypertrophic Cardiomyopathy Progression

  2025cites this paper
• Artificial intelligence electrocardiogram as a novel screening tool to detect and longitudinally monitor high-risk echocardiographic features in hypertrophic cardiomyopathy

  2025cites this paper
• Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan: Reconciling the American and European Approaches.

  2025cites this paper
• Short- and Long-Term Outcomes of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Diretriz sobre Diagnóstico e Tratamento da Cardiomiopatia Hipertrófica – 2024

  2024cites this paper
• Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024

  2024cites this paper
• 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

  2024cites this paper
• 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

  2024cites this paper
• Distinct Phenotypic Groups and Related Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy

  2024cites this paper
• Short-term effect of repeat echocardiographic screening for detection or confirmation of hypertrophic cardiomyopathy.

  2024cites this paper
• Clinical features and postoperative outcomes in elderly patients undergoing septal myectomy for hypertrophic cardiomyopathy.

  2024cites this paper
• Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy

  2024cites this paper
• Association between age or duration of diagnosis in obstructive hypertrophic cardiomyopathy and response to mavacamten treatment: Exploratory analysis of the EXPLORER-HCM trial.

  2024cites this paper
• Reported Physical Symptoms During Screening Echocardiography Are Not Associated With Presence of Suspected Hypertrophic Cardiomyopathy

  2024cites this paper
• Hypertension and its association to phenotype on left ventricular function in hypertrophic cardiomyopathy patients assessed by cardiovascular magnetic resonance imaging.

  2024cites this paper
• Machine Learning-Based Discrimination of Cardiovascular Outcomes in Patients With Hypertrophic Cardiomyopathy

  2024cites this paper
• The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.

  2024cites this paper
• Machine learning and physical based modeling for cardiac hypertrophy

  2023cites this paper
• Impact of coronary artery revascularization on long-term outcome in hypertrophic cardiomyopathy patients: a nationwide population-based cohort study

  2023cites this paper
• Diagnosing Hypertrophic Cardiomyopathy in Athletes

  2023cites this paper
• Clinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States.

  2023cites this paper
• Computational modeling of electromechanical coupling in human cardiomyocyte applied to study hypertrophic cardiomyopathy and its drug response

  2023cites this paper
• The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study

  2023cites this paper
• Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.

  2023cites this paper
• Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy

  2023cites this paper
• Impact of a Center of Excellence in Confirming or Excluding a Diagnosis of Hypertrophic Cardiomyopathy

  2023cites this paper
• Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy

  2023cites this paper
• Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy

  2023cites this paper
• Mechanism of Ion Channel Impairment in the Occurrence of Arrhythmia in Patients with Hypertrophic Cardiomyopathy

  2023cites this paper
• The use of cardiac magnetic resonance in hypertrophic cardiomyopathy over the past 10 years [2013–2023]: a CiteSpace-based bibliometric analysis

  2023influential citation
• 2023 Canadian Cardiovascular Society Guidelines on the Fitness to Drive.

  2023cites this paper
• Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by Echocardiogram: A Case Presentation

  2023cites this paper
• Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.

  2023cites this paper
• Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan: Reconciling the American and European Approaches.

  2023cites this paper
• Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy

  2023cites this paper
• Impact of coronary artery disease in patients with hypertrophic cardiomyopathy.

  2023cites this paper
• Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure.

  2022cites this paper
• Surgical treatment of hypertrophic obstructive cardiomyopathy in relatively elderly patients: Short- and long-term outcomes.

  2022cites this paper
• Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy

  2022cites this paper
• Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.

  2022cites this paper
• Hypertrophic Cardiomyopathy: New Concepts and Therapies.

  2022cites this paper
• Predicting sudden cardiac death in genetic heart disease.

  2022cites this paper
• Patients with hypertrophic cardiomyopathy are getting older.

  2022cites this paper
• Comparison of mortality and cause of death between adults with and without hypertrophic cardiomyopathy

  2022cites this paper
• 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

  2022cites this paper
• Artificial Intelligence–Enabled Model for Early Detection of Left Ventricular Hypertrophy and Mortality Prediction in Young to Middle-Aged Adults

  2022cites this paper
• Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation

  2022cites this paper
• Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator

  2022cites this paper
• Hypertrophic Cardiomyopathy and Exercise: Mutually Exclusive or Beneficial?

  2022cites this paper
• Temporal Changes in Cardiac Morphology and Its Relationship with Clinical Characteristics and Outcomes in Patients with Hypertrophic Cardiomyopathy.

  2022cites this paper
• Advances in hypertrophic cardiomyopathy: What the cardiologist needs to know.

  2022cites this paper
• Right Ventricular Enlargement and Dysfunction Are Associated With Increased All-Cause Mortality in Hypertrophic Cardiomyopathy.

  2022cites this paper
• Risk factors, clinical features, and outcomes of patients with hypertrophic cardiomyopathy complicated by ischemic stroke: A single-center retrospective study

  2022cites this paper
• Transaortic Shallow Septal Myectomy and Cutting of Secondary Fibrotic Mitral Valve Chordae—A 5-Year Single-Center Experience in the Treatment of Hypertrophic Obstructive Cardiomyopathy

  2022cites this paper
• Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging

  2022cites this paper
• Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model

  2021cites this paper
• Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy

  2021cites this paper
• A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy

  2021cites this paper
• Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Diagnosis, Clinical Course and Therapy

  2021cites this paper
• Hypertrophic Cardiomyopathy-Anesthesia Considerations for Septal Myectomy

  2021cites this paper
• Septuagenarians with hypertrophic obstructive cardiomyopathy undergoing myectomy: the experience of a single center

  2021cites this paper
• An Unusual Case of Shock in an Octogenarian

  2021cites this paper
• Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning

  2021cites this paper
• 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis).

  2021cites this paper
• Surgical Septal Myectomy for the Treatment of Residual Left Ventricular Outflow Tract Obstruction Following Failed Alcohol Septal Ablation.

  2021cites this paper
• Circulation: Cardiovascular Quality and Outcomes

  2021cites this paper
• Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy

  2021cites this paper
• Prognostic implications of different clinical profiles in hypertrophic cardiomyopathy.

  2021cites this paper
• EVOLUTION OF RISK STRATIFICATION AND SUDDEN DEATH PREVENTION IN HYPERTROPHIC CARDIOMYOPATHY: 20 YEARS WITH THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR.

  2021cites this paper
• Patterns of Left Ventricular Hypertrophy and Late Gadolinium Enhancement on Cardiac MRI in Patients with Hypertrophic Cardiomyopathy and their Prognostic Significance – An Experience from a South Asian Country

  2021cites this paper
• Miocardiopatías. Miocardiopatía hipertrófica

  2021cites this paper
• Sex and Race Disparities in Hypertrophic Cardiomyopathy: Unequal Implantable Cardioverter-Defibrillator Use During Hospitalization.

  2021cites this paper
• Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy

  2021cites this paper
• Thromboembolism in Patients with Hypertrophic Cardiomyopathy

  2021cites this paper
• Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach

  2021cites this paper
• Risk factors of sudden cardiac death in hypertrophic cardiomyopathy

  2021cites this paper
• N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy.

  2021cites this paper
• Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy

  2021cites this paper
• Atrial fibrillation in hypertrophic cardiomyopathy: pathophysiology, diagnosis and management.

  2020cites this paper
• 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2020cites this paper
• Genetics, insurance and hypertrophic cardiomyopathy

  2020cites this paper
• Epidemiology of Pediatric Hypertrophic Cardiomyopathy in a 10-Year Medicaid Cohort

  2020cites this paper
• Will genetic test results be monetized in life insurance?

  2020cites this paper
• Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy

  2020cites this paper